HOMECONTACTSITE MAPSEARCH

Stock Information
NASDAQ:INFI
$6.18   - 0.03
Feb 8, 2010
3:59 PM ET
Quotes delayed at least 20 minutes. Data provided by eSignal.
Investors and Media Relations

The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug discovery and development.

We believe that our small molecule discovery and development capabilities, strategic alliances, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients.


Events

Feb 10, 2010
Infinity Pharmaceuticals Fourth Quarter 2009 Results

Jan 14, 2010
J.P. Morgan 28th Annual Healthcare Conference

more »

Annual Report


Click here to view the 2008 Annual Report PDF


Recent Releases

Feb 3, 2010
Infinity Announces 2009 Financial Results Conference Call

Jan 11, 2010
Infinity Announces Key 2010 Objectives

more »

Request Investor Kit
Shareholder Briefcase
Receive Email Alerts
Subscribe to News
Search
© 2001-2010 Infinity Pharmaceuticals, Inc. All rights reserved. | Terms | Forward Looking Statements | Privacy